LW

Lisheng Wang

empowering innovations and impact

📍 United States🔄 Updated September 2026💼 26 investments📅 10 years investing🗓 Last invested Jan 2023
VC🌍 United States20+ investments
26
Total investments
9
Early stage
11
Mid stage
2
Late stage
10y
Years active

Portfolio

25 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2023
LEADOPTIK Inc. is a deep-tech startup based in San Jose, California. We are building miniature imaging platform for minimally invasive procedures.
Investor
2023
Ultron.AI offers a transformative solution for guaranteed product identification, all without needing any AI training. Our platform enables retailers and retail ISVs to create scalable solutions for critical applications such as loss prevention, self-checkout, inventory tracking, and "just walk out" shopping experiences. And thats just the beginning; the potential applications are endless. What sets our technology apart is its speed and precision. While other systems might take weeks or even months to recognize a new product and be affected by variations between stores, we can start identifying hundreds of thousands of products in minutes. Plus, we can do this regardless of differences in product angles, lighting conditions, or other visual challenges, and with industry-leading accuracy. This opens the door to new and innovative ways to improve the retail experience.
Investor
2023
Forta is clearing the path to quality healthcare. We continuously improve the patient journey and deliver personalized care by applying AI and machine learning. The first care vertical Forta is improving is autism ABA therapy. Care is difficult to access and the delivery model must be reinvented to provide early access to families. 1 in 44 children [CDC, 2021] is diagnosed to be on the autism spectrum. We are looking for driven, innovative, patient-focused individuals to join our team as we reinvent the care and tools available to neurodiverse families.
Investor / Advisor
2023
In the near future, surgery will be incisionless.
Board Member
Sep 2022
What if you were able to unleash innovations, grow great businesses, and truly impact the way we live? And what if you could do it while potentially achieving investment returns? Propel(x) is making that vision a reality. As a premier digital platform facilitating private venture capital for Deep Tech innovation, our mission is to enable investments in technologies that matter and thus build the next generation of great companies. For Accredited Investors, Financial Advisors and Funds - Get early access to deep technology deal flow and leverage our due diligence capabilities to make an informed investment decision. For Deep Tech Startup Founders - Get discovered by investors committed to funding deep tech innovation. Aggregate investments from multiple angel investors handled into a single investment vehicle. Newton Fund, managed by Propel(x) Advisors, a Propel(x) subsidiary is a seed stage investment firm with a focus on deep tech start ups. Our goal is to propel mankind by helping finance technologies that matter, such as Life Sciences, IT & Communications, Industrial Technologies, Food & Agriculture, Energy & Green Technologies and Aerospace & Transportation. We invest typically in startups that appear on the Propel(x) platform. For questions , please email us at info@propelx.com
Investor
2021
CAGE Bio Inc. is a privately-held clinical-stage company exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for dermatology, inflammation, and immunology
mid stageBiotechnology
Investor
2021
Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.
Investor
2021
Hayden AI powers safer, smarter, and more efficient cities. We combine advanced vision AI with purpose-built, vehicle-mounted hardware to analyze urban environments real-time. Cities use our technology to make streets safer and improve transit performance for everyone. Learn more at www.hayden.ai 
Investor
2021
Genomelink is a DNA App Store where people upload and store DNA data to access more insights, products, and health research. We are on missions to; - Build a world #1 consumer application platform - Help advancement of genomics and health science - Bring back DNA data ownership to your hand
mid stageBiotechnology
Investor
2020
BRELYON is a deep tech, venture-backed Silicon Valley-based startup that is introducing a new category of immersive displays to bring metaverse on to your desk. We post on topics about metaverse, computer graphics, gaming industry, AR, VR, lightfield displays and 3D displays. Join the community!
Investor
2020
Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action. MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
early stageBiotechnology
Investor
2019
SkyCool Systems is a clean energy company focused on energy efficient solutions and new methods for cooling.
Investor
2019
APERIO is the leader in industrial data quality solutions. We help customers drive profitability and sustainability goals while mitigating risk in their industrial operations. Powered by AI machine learning, APERIO automatically validates operational data at scale to improve data accuracy, security, and value, allowing for better, smarter business decisions based on real-time, trusted, superior data.
Investor
2019
We are a spin out from the Langer & Karp Labs developing advanced materials for injury prevention. We have two cutting edging, technologies in development. The first is a coating for a battery to reduce the risk of injuries associated with button battery ingestion in children. The second is a medical tape for fragile skin populations.
Investor
2018
Accelerate Additive Manufacturing Accuracy with 3D Reality. Riven is an open cloud software company accelerating high-precision additive manufacturing. Our Warp-Adapted-Model (WAM) software applies proprietary 3D reality intelligence to correct and prevent dimensional defects. Riven enables OEMs and service bureaus to meet demanding quality specifications at production scale and expands additive manufacturing applications. Riven is used across a variety of additive manufacturing methods including MJF, FDM, SLA and metal binder jetting.
Show all 25 investments ↓
Experience · 33 entries
All (33)
Investments (26)
Founder (1)
Board (1)
2023
Investor
2023
LEADOPTIK Inc. is a deep-tech startup based in San Jose, California. We are building miniature imaging platform for minimally invasive procedures.
General Partner
2023
Backing pre-seed and seed stage startups working on Digital Transformation, Healthcare, and Sustainability.
Investor
2023
Ultron.AI offers a transformative solution for guaranteed product identification, all without needing any AI training. Our platform enables retailers and retail ISVs to create scalable solutions for critical applications such as loss prevention, self-checkout, inventory tracking, and "just walk out" shopping experiences. And thats just the beginning; the potential applications are endless. What sets our technology apart is its speed and precision. While other systems might take weeks or even months to recognize a new product and be affected by variations between stores, we can start identifying hundreds of thousands of products in minutes. Plus, we can do this regardless of differences in product angles, lighting conditions, or other visual challenges, and with industry-leading accuracy. This opens the door to new and innovative ways to improve the retail experience.
Managing Director
2023
Concordia is dedicated to empowering immigrant talents through its unwavering commitment to supporting educational and socially inclusive programs across Asia and North America. Concordia envisions itself as a dynamic platform fostering cultural exchange and facilitating economic cooperation among kindred spirits from both sides of the Pacific. People behind Concordia are a select cadre of immigrant entrepreneurs who left their legacies by spearheading technology companies to multiple billion-dollar exits. They continue to extend their impact to this day by nurturing the next generation of entrepreneurs and backing meaningful technology ventures from their earliest days.
Investor
2023
Forta is clearing the path to quality healthcare. We continuously improve the patient journey and deliver personalized care by applying AI and machine learning. The first care vertical Forta is improving is autism ABA therapy. Care is difficult to access and the delivery model must be reinvented to provide early access to families. 1 in 44 children [CDC, 2021] is diagnosed to be on the autism spectrum. We are looking for driven, innovative, patient-focused individuals to join our team as we reinvent the care and tools available to neurodiverse families.
Show all 33 entries ↓
Investment activity
2016–2023 · 26 investments
2016120172201882019320203202142022120234
Recent (last 2 years)Earlier